FDA redesigns its drug shortage Web page to make it easier to quickly locate current shortage information.
FDA releases a draft guidance to help sponsors with clinical development of drugs to treat major depressive disorder.
Four stakeholders raise concerns with an FDA docket and draft guidance on quality considerations for metered dose and dry powder inhalers.
Yale University researchers caution that right-to-try laws can upset the balance between access and safety FDA has reached with drug manufacturers in ...
FDA releases its latest batch of Warning Letters that include Biologique Recherche and Oeyama-Moto Medical Group Foundation.
FDA commissioner Scott Gottlieb describes two new initiatives he wants to have funding in the agencys next budget to further promote generic drug deve...
FDA warns Frances Biologique Recheche about CGMP violations in its production of finished drugs.
FDA approves two Grifols blood screening assays: Procleix Ultrio Elite and Procleix WNV.